ABOS
NASDAQ
$2.21
Acumen Pharmaceuticals Inc (ABOS)
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies for the treatment of Alzheimer's disease and other neurodegenerative diseases. The company is headquartered in Charlottesville, Virginia.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.40 (+234.84%)
Market Cap
$160M
Free Cash Flow Yield
-65.82%
Beta (5Y)
1.44
Price Chart
Valuation
Market Cap$160M
P/S538.78
P/B2.09
Profitability
Gross Profit (TTM)-$105M
EBITDA-$115M
EPS-$1.81
Financial Health
Debt-to-Equity35.5%
Free Cash Flow Yield-65.82%
Growth & Risk
Beta (5Y)1.44
Sharpe Ratio0.84